Process evaluation of a tailored intervention to Reduce Inappropriate psychotropic Drug use in nursing home residents with dementia

Process evaluation of a tailored intervention to Reduce Inappropriate psychotropic Drug use in nursing home residents with dementia

Abstract Background Research suggests that collaborative and tailored approaches with external expertise are important to process implementations. We therefore performed a process evaluation of an intervention using participatory action research, tailored information provision, and external coaching...

Full description

Bibliographic Details
Main Authors:	Claudia M. Groot Kormelinck, Charlotte F. van Teunenbroek, Sytse U. Zuidema, Martin Smalbrugge, Debby L. Gerritsen
Format:	Article
Language:	English
Published:	BMC 2021-07-01
Series:	BMC Geriatrics
Subjects:	Process evaluation Complex intervention Participatory action research Nursing home Neuropsychiatric symptoms Psychotropic drugs
Online Access:	https://doi.org/10.1186/s12877-021-02357-w

Similar Items

Reducing inappropriate psychotropic drug use in nursing home residents with dementia: protocol for participatory action research in a stepped-wedge cluster randomized trial
by: Claudia M. Groot Kormelinck, et al.
Published: (2019-10-01)

Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report
by: Michaela Defrancesco, et al.
Published: (2020-05-01)

Prevalences and Indications of Psychotropic Drug Prescriptions in Nursing Home Residents with Korsakoff Syndrome
by: Ineke J. Gerridzen, et al.
Published: (2023-04-01)

The impact of medication reviews by general practitioners on psychotropic drug use and behavioral and psychological symptoms in home-dwelling people with dementia: results from the multicomponent cluster randomized controlled LIVE@Home.Path trial
by: Marie H. Gedde, et al.
Published: (2022-05-01)

Severity of Neuropsychiatric Symptoms in Nursing Home Residents
by: Anne-Sofie Helvik, et al.
Published: (2016-01-01)

Syndrome-Based Prescription to Optimize Psychotropics: Are CHROME Criteria a Game Changer?
by: Ruben Muñiz, et al.
Published: (2021-04-01)

A retrospective comparison of inappropriate prescribing of psychotropics in three Norwegian nursing homes in 2000 and 2016 with prescribing quality indicators
by: Jan Schjøtt, et al.
Published: (2019-05-01)

The construction of a conceptual framework explaining the relation between barriers to change of management of neuropsychiatric symptoms in nursing homes: a qualitative study using focus groups
by: Charlotte F. van Teunenbroek, et al.
Published: (2020-05-01)

Losing hope or keep searching for a golden solution: an in-depth exploration of experiences with extreme challenging behavior in nursing home residents with dementia
by: Annelies E. Veldwijk-Rouwenhorst, et al.
Published: (2022-09-01)

Effects of a music therapy and music listening intervention for nursing home residents with dementia: a randomized controlled trial
by: Anna-Eva J. C. Prick, et al.
Published: (2024-02-01)

The Neuropsychiatric Inventory-Diary Rating Scale (NPI-Diary): A Method for Improving Stability in Assessing Neuropsychiatric Symptoms in Dementia
by: Francesca Morganti, et al.
Published: (2018-09-01)

The longitudinal patterns of psychotropic drug prescriptions for subpopulations of community-dwelling older people with dementia: electronic health records based retrospective study
by: Jiamin Du, et al.
Published: (2023-03-01)

Psychotropic medication use in Swiss nursing homes
by: I Lustenberger, et al.
Published: (2011-09-01)

Do prescription rates of psychotropic drugs change over three years from nursing home admission?
by: Enrico Callegari, et al.
Published: (2021-09-01)

Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients
by: Mireia Massot Mesquida, et al.
Published: (2019-01-01)

Glaucoma and Psychotropics
by: T. Cavaco, et al.
Published: (2022-06-01)

COVID-19: Neuropsychiatric manifestations and psychopharmacology
by: Harpreet Singh Dhillon, et al.
Published: (2020-01-01)

Effects of Caregiver Dementia Training in Caregiver–Patient Dyads on Psychotropic Drug Prescription: A Randomized Controlled Study
by: Birkenhäger-Gillesse EG, et al.
Published: (2021-07-01)

The effectiveness of creating an online life story book on persons with early dementia and their informal caregivers: a protocol of a randomized controlled trial
by: Teuntje R Elfrink, et al.
Published: (2017-04-01)

Ten-Year Trends in Psychotropic Prescribing and Polypharmacy in Australian General Practice Patients with and without Dementia
by: Woldesellassie M. Bezabhe, et al.
Published: (2023-05-01)

Investigating the effects of impairment in non‐verbal communication on neuropsychiatric symptoms and quality of life of people living with dementia
by: Zunera Khan, et al.
Published: (2021-01-01)

Impaired Awareness in People with Severe Alcohol-Related Cognitive Deficits Including Korskoff’s Syndrome: A Network Analysis
by: Hester Fidder, et al.
Published: (2023-04-01)

Patterns of psychotropic drug prescriptions and general practice consultations among community-dwelling older people with dementia during the first two years of the COVID-19 pandemic
by: Jiamin Du, et al.
Published: (2024-02-01)

Jurisprudential study of psychotropic drugs and narcotics
by: Leila Jahanbin
Published: (2021-04-01)

A delicate balance: Psychotropic polypharmacy and anti‐cholinergic use are correlated with fall incidence in Australian inpatients with dementia
by: Samuel X. Tan, et al.
Published: (2021-09-01)

Current Pattern of Psychiatric Comorbidity and Psychotropic Drug Prescription in Child and Adolescent Patients
by: Mengühan Araz Altay, et al.
Published: (2019-05-01)

Pain and quality of life in nursing home residents with dementia after admission – a longitudinal study
by: Anne-S. Helvik, et al.
Published: (2023-09-01)

Behavioral and Psychological Symptoms of Dementia
by: Joaquim eCerejeira, et al.
Published: (2012-05-01)

Neuropsychiatric symptoms and severity of dementia
by: Gustavo Henrique de Oliveira Caldas, et al.

Person-centered, non-pharmacological intervention in reducing psychotropic medications use among residents with dementia in Australian rural aged care homes
by: Daya Ram Parajuli, et al.
Published: (2021-01-01)

Neuropsychiatric symptoms in patients with vascular dementia in mainland China
by: Jin Yan-ling, et al.
Published: (2015-01-01)

Impact of Social Isolation on the Behavioral, Functional Profiles, and Hippocampal Atrophy Asymmetry in Dementia in Times of Coronavirus Pandemic (COVID-19): A Translational Neuroscience Approach
by: Aida Muntsant, et al.
Published: (2020-11-01)

Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary
by: Julie M. Zito, et al.
Published: (2021-06-01)

A bitter pill to swallow - Polypharmacy and psychotropic treatment in people with advanced dementia
by: Lina Riedl, et al.
Published: (2022-03-01)

Factors Associated with Psychotropic Medications Literacy among Community Pharmacists
by: Abdelrahim Alqudah, et al.
Published: (2023-03-01)

CHARACTERISTICS OF COMSUMPTION OF PSYCHOTROPIC DRUGS AMONG STUDENTS OF HEALTH SCIENCES
by: Gloria I. MARTÍNEZ D., et al.
Published: (2009-02-01)

Prescribing pattern of anti-psychotic medications in patients with dementia in Oman: a retrospective observational study
by: Zainab Al-Rashdi, et al.
Published: (2023-01-01)

Psychotropic stewardship: Advancing patient care
by: Haight Robert J. PharmD, BCPP, et al.
Published: (2023-04-01)

How and when to use psychotropic drugs in psychodermatology
by: Sharmishtha S Deshpande, et al.
Published: (2023-01-01)

Specificities of the Use of Psychotropic Drugs in Bariatric Surgery
by: C. Fernandes Santos, et al.
Published: (2022-06-01)